Cargando…

Serum Tumor Markers in Pancreatic Cancer—Recent Discoveries

The low prevalence of pancreatic cancer remains an obstacle to the development of effective screening tools in an asymptomatic population. However, development of effective serologic markers still offers the potential for improvement of diagnostic capabilities, especially for subpopulations of patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rückert, Felix, Pilarsky, Christian, Grützmann, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2010
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835121/ https://www.ncbi.nlm.nih.gov/pubmed/24281109 http://dx.doi.org/10.3390/cancers2021107

Ejemplares similares

The Role of Apoptosis in the Pathology of Pancreatic Cancer
por: Samm, Nicole, et al.
Publicado: (2010)

Molecular Pathogenesis of Pancreatic Neuroendocrine Tumors
por: Ehehalt, Florian, et al.
Publicado: (2010)

Feedback within the Inter-Cellular Communication and Tumorigenesis in Carcinomas
por: Rückert, Felix, et al.
Publicado: (2012)

The Role of Exosomes in Pancreatic Cancer
por: Lan, Bin, et al.
Publicado: (2019)

Simultaneous gene silencing of Bcl-2, XIAP and Survivin re-sensitizes pancreatic cancer cells towards apoptosis
por: Rückert, Felix, et al.
Publicado: (2010)

c-Met and PD-L1 on Circulating Exosomes as Diagnostic and Prognostic Markers for Pancreatic Cancer
por: Lux, Alexander, et al.
Publicado: (2019)

Chemoresistance in Pancreatic Cancer
por: Zeng, Siyuan, et al.
Publicado: (2019)

Evaluation of survival in patients after pancreatic head resection for ductal adenocarcinoma
por: Distler, Marius, et al.
Publicado: (2013)

Current Clinical Strategies of Pancreatic Cancer Treatment and Open Molecular Questions
por: Brunner, Maximilian, et al.
Publicado: (2019)

Neoadjuvant Therapy in Patients with Pancreatic Cancer: A Disappointing Therapeutic Approach?
por: Zimmermann, Carolin, et al.
Publicado: (2011)

Precursor Lesions for Sporadic Pancreatic Cancer: PanIN, IPMN, and MCN
por: Distler, M., et al.
Publicado: (2014)

Silenced ZNF154 Is Associated with Longer Survival in Resectable Pancreatic Cancer
por: Wiesmueller, Felix, et al.
Publicado: (2019)

Examination of Apoptosis Signaling in Pancreatic Cancer by Computational Signal Transduction Analysis
por: Rückert, Felix, et al.
Publicado: (2010)

Identification of Prognostic Biomarkers by Combined mRNA and miRNA Expression Microarray Analysis in Pancreatic Cancer
por: Liu, Bin, et al.
Publicado: (2018)

CRISPR/Cas9-Mediated Knock-Out of Kras(G12D) Mutated Pancreatic Cancer Cell Lines
por: Lentsch, Eva, et al.
Publicado: (2019)

Chronic pancreatitis of the pancreatic remnant is an independent risk factor for pancreatic fistula after distal pancreatectomy
por: Distler, Marius, et al.
Publicado: (2014)

An m5C methylation regulator-associated signature predicts prognosis and therapy response in pancreatic cancer
por: Yun, Duo, et al.
Publicado: (2022)

Impact of CRISPR/Cas9-Mediated CD73 Knockout in Pancreatic Cancer
por: Zhang, Jinping, et al.
Publicado: (2023)

Recent Discoveries of Diagnostic, Prognostic and Predictive Biomarkers for Pancreatic Cancer
por: Khomiak, Andrii, et al.
Publicado: (2020)

Microbiome Patterns in Matched Bile, Duodenal, Pancreatic Tumor Tissue, Drainage, and Stool Samples: Association with Preoperative Stenting and Postoperative Pancreatic Fistula Development
por: Langheinrich, Melanie, et al.
Publicado: (2020)

Activation of Wnt signalling in stroma from pancreatic cancer identified by gene expression profiling
por: Pilarsky, Christian, et al.
Publicado: (2008)

Identification of Genes Associated with Liver Metastasis in Pancreatic Cancer Reveals PCSK6 as a Crucial Mediator
por: He, Hang, et al.
Publicado: (2022)

Google Goes Cancer: Improving Outcome Prediction for Cancer Patients by Network-Based Ranking of Marker Genes
por: Winter, Christof, et al.
Publicado: (2012)

Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma
por: Rückert, F, et al.
Publicado: (2008)

CRISPR Cas9 in Pancreatic Cancer Research
por: Yang, Hai, et al.
Publicado: (2019)

Pre-clinical Models of Metastasis in Pancreatic Cancer
por: Miquel, Maria, et al.
Publicado: (2021)

CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer
por: Lan, Bin, et al.
Publicado: (2022)

Genome-Wide CRISPR Screening Identifies DCK and CCNL1 as Genes That Contribute to Gemcitabine Resistance in Pancreatic Cancer
por: Yang, Hai, et al.
Publicado: (2022)

The G Protein-Coupled Receptor RAI3 Is an Independent Prognostic Factor for Pancreatic Cancer Survival and Regulates Proliferation via STAT3 Phosphorylation
por: Jahny, Elisabeth, et al.
Publicado: (2017)

Metabolic biomarkers for the differential diagnosis of pancreatic ductal adenocarcinoma vs. chronic pancreatitis
por: Mayerle, Julia, et al.
Publicado: (2014)

Recent Advances in Proteomics and Cancer Biomarker Discovery
por: Xiao, Gary Guishan, et al.
Publicado: (2008)

Deep Learning Improves Pancreatic Cancer Diagnosis Using RNA-Based Variants
por: Al-Fatlawi, Ali, et al.
Publicado: (2021)

Proposal of a Standardized Questionnaire to Structure Clinical Peer Reviews of Mortality and Failure of Rescue in Pancreatic Surgery
por: Brunner, Maximilian, et al.
Publicado: (2021)

Screening for pancreatic cancer in individuals with genetic susceptibility
por: Grützmann, Robert, et al.
Publicado: (2023)

Gene expression profiling of liver metastases and tumour invasion in pancreatic cancer using an orthotopic SCID mouse model
por: Niedergethmann, M, et al.
Publicado: (2007)

CDK7 inhibition augments response to multidrug chemotherapy in pancreatic cancer
por: Zeng, Siyuan, et al.
Publicado: (2022)

Prognostic impact of a compartment-specific angiogenic marker profile in patients with pancreatic cancer
por: Kahlert, Christoph, et al.
Publicado: (2014)

Identification and validation of a multivariable prediction model based on blood plasma and serum metabolomics for the distinction of chronic pancreatitis subjects from non-pancreas disease control subjects
por: Adam, M Gordian, et al.
Publicado: (2021)

Discovery of Tumor Markers for Gastric Cancer by Proteomics
por: Wu, Jeng-Yih, et al.
Publicado: (2014)

Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis
por: Mayerle, Julia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tjf98c3m2ie4q9h5hc5h4q3gs0